BOSTON - A Massachusetts federal judge on March 30 dismissed a purported class action by shareholders of Genzyme Corp., finding that the plaintiffs failed to show scienter that the company and its executives failed to disclose problems at manufacturing plants and with one of its biologic drugs and inflated...

NEW YORK - A New York federal judge overseeing the Pfizer Inc. securities multidistrict litigation on March 29 certified a class of shareholders who allege that their stock value was affected by misstatements and omissions concerning the safety of the pain drugs Celebrex and Bextra (In Re: Pfizer Inc...

CHICAGO - Finding that a pension fund's pleadings were superior to those of other movants, a federal judge in Illinois on April 13 appointed the pension fund as lead plaintiff in a shareholder derivative lawsuit against a drug company that allegedly had marketed a drug for uses for which it had not...

GRAND RAPIDS, Mich. - A federal judge in Michigan on Nov. 29 approved a settlement between a group of shareholders and directors and officers of a corporation that puts in place certain corporate governance measures (Westchester Putnam Counties Heavy and Highway Laborers Local 60 Benefit Funds, et al...

NEWARK, N.J. - A federal judge in New Jersey on Oct. 1 granted final approval of a $688 million settlement in two securities class action lawsuits alleging that Merck and Co. Inc. and others failed to disclose adverse results of a clinical trial for two cholesterol drugs Merck was developing (In Re:...

WASHINGTON, D.C. - Medical device manufacturer ArthroCare Corp. will pay a $30 million monetary penalty to settle claims that certain of its senior executives engaged in a securities fraud scheme that bilked the company's shareholders out of more than $400 million, according to a press release issued...